Prognostic importance of interleukin 2 receptor for patients with a history of cirrhotic variceal bleeding

Objectives Variceal hemorrhage is a fatal complication of cirrhosis. In this study, we aimed to investigate the role of serum interleukin 2 receptor (sIL‐2R) as a predictive indicator in patients with a previous history of cirrhosis‐related variceal bleeding. Methods A total of 340 cirrhotic patients who had experienced variceal bleeding from December 2016 to December 2018 were enrolled, and were randomly assigned to the modeling group and the validation group. The 3‐year variceal rebleeding rate and other outcomes including adverse events were analyzed between patients with different sIL‐2R levels. Results A time‐dependent receiver operating characteristic (ROC) curve of variceal rebleeding indicated that sIL‐2R had an area under the ROC curve (AUROC] of 0.731 and 0.837 for the modeling and validation groups, respectively, with a cut‐off value of 426 U/mL. Kaplan–Meier analysis showed that higher sIL‐2R level was related to an increased risk of variceal rebleeding rate (55.33% vs 24.34%, P = 0.024 and 51.28% vs 15.32%, P = 0.049) and decreased 3‐year survival rate (91.16% vs 98.92%, P = 0.013 and 90.52% vs 97.50%, P = 0.180) in the modeling and validation groups. Elevated sIL‐2R levels were associated with an increased risk of portal vein thrombosis and severe ascites as well as inferior liver function, hypercoagulable state, and increased portal pressure. Conclusion High sIL‐2R levels were associated with poor prognosis in cirrhotic patients with previous variceal bleeding.